Corporate Finance

Total investment in energy storage fell to $16.2B in 2025, but a 30% surge in venture capital and strong M&A activity reveal a strategic market shift.

A new unmanned aircraft just flew for 2.5 days straight, signaling a major shift in persistent surveillance for military, security, and commercial sectors.

Cincinnati's Timber Bay Partners oversubscribes its fund, proving investor appetite for specialized strategies in the booming GP-led secondary market.

A nationwide study, with NFL legend Steve Gleason as Participant #1, seeks to uncover why high-performance groups face a disproportionate risk of ALS.

Following a major restructuring, FLSmidth appoints Toni Laaksonen as CEO to accelerate growth and capitalize on its new pure-play mining focus.

A new report reveals AI's efficiency promise is a myth, as marketers lose hours to fact-checking and over a third publish inaccurate AI content.

With Warren Seubel leading sales, Opto Investments aims to reshape private market access for wealth managers using its advanced AI and fiduciary-first model.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

Floyd Mayweather will face kickboxing icon Mike Zambidis in a 2026 Athens exhibition, blurring the lines between sport, legacy, and big-money entertainment.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

With a new AWS competency and proprietary AI tools, this firm is helping small businesses tackle big tech challenges like legacy system modernization.

With $130M in total funding, AI-scent pioneer Osmo is expanding its team to disrupt the fragrance market and unlock new frontiers in health and safety.

FactSet's new AI Doc Ingest for Cobalt promises to slash data entry from days to minutes without costly model training, a potential game-changer for PE firms.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

Nataly M. Marks, President of Triple-S Steel, joins the MSC Income Fund board, bringing deep operational and financial expertise to its investment strategy.

A landmark survey reveals a massive capital rotation as 96% of institutions chase AI and 81% move to private markets to navigate a fragmenting world.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?